PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology.
Procept Biorobotics stock last closed at $26.17, down 4.35% from the previous day, and has decreased 54.11% in one year. It has overperformed other stocks in the Medical Devices industry by 0.12 percentage points. Procept Biorobotics stock is currently +35.25% from its 52-week low of $19.35, and -60.85% from its 52-week high of $66.85.
There are currently 56.39M shares of PRCT outstanding. The market capitalization of PRCT is $1.48B. In the last 24 hours, 1.46M PRCT shares were traded.
How to Buy Procept Biorobotics Stock
Wondering how to invest in Procept Biorobotics stock? Here's how.
Figure out where to buy Procept Biorobotics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Procept Biorobotics stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Put funds into your brokerage account: Pick your payment method and add your details.
Evaluate Procept Biorobotics stock: The Procept Biorobotics ticker symbol is PRCT. Is Procept Biorobotics stock a good investment? Should you buy shares of PRCT? How do PRCT's underlying business fundamentals look? Do top analysts think Procept Biorobotics is a good buy? Why has PRCT's stock price moved recently? (Hint: Our stock market research tools can help you figure out if PRCT is a good stock to buy).
Place your PRCT trade: Decide if you will purchase PRCT shares at the current market price or use a limit order to buy PRCT shares at a particular price.
Get key alerts regarding your PRCT investment: Create a watchlist to get the latest news on your investment in Procept Biorobotics stock.
Step 1: Figure out where to buy Procept Biorobotics stock
You will need an online brokerage account in order to access the NASDAQ market and buy PRCT stock.
A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected the best brokerage, you need to fill out some personal details so you can buy PRCT today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Procept Biorobotics stock
After you have identified the best place to buy Procept Biorobotics stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk as well as the upside.
Overview of key PRCT info
PRCT Price
$26.17
1w %
-5.86%
1y %
-54.11%
5y %
N/A
P/E
-15.22x
P/B
4.03x
P/S
4.72x
PEG
N/A
Revenue
$308.05M
Earnings
-$95.57M
Fore. Rev. Growth
24.8%
Fore. Earn. Growth
N/A
Market Cap
$1.48B
Next Earnings
Apr 30, 2026
Next Dividend
N/A
Fundamentals of Procept Biorobotics
WallStreetZen was built to help average investors perform more accurate fundamental analysis quickly.
There are more short-term assets than long-term liabilities on the PRCT balance sheet.
There are more short-term assets than short-term liabilities on the PRCT balance sheet.
PRCT has cash burn of 58341000. It has enough cash and short-term investments to cover this for at least one year.
PRCT has a low debt to equity ratio of 0.39.
Total PRCT debt is lower than 5 years ago, relative to shareholder equity.
PRCT has $286.50M in cash and short term investments. This is enough to cover its annual cash burn of $58.34M.
Failed Financial Due Diligence Checks:
PRCT profit margin has gone up by 0.1 percentage points in the past year, but the company is still unprofitable.
Is PRCT stock a Buy, Hold, or Sell, according to analysts?
Out of 9 Equities analysts who track PRCT, the consensus analyst rating on Procept Biorobotics is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest PRCT Analyst Forecasts
Nathan Treybeck, a bottom 14% analyst from Wells Fargo maintains PRCT with a strong buy rating and lowers their PRCT price target from $51.00 to $34.00, on Feb 26, 2026.
Craig Bijou, a top 7% analyst from Bank of America downgrades PRCT to a sell rating and lowers their PRCT price target from $38.00 to $20.00, on Feb 26, 2026.
Danielle Antalffy, a bottom 4% analyst from UBS initiates coverage on PRCT with a strong buy rating and announces their PRCT price target of $62.00, on Dec 12, 2025.
Patrick Wood, a top 30% analyst from Morgan Stanley maintains PRCT with a strong buy rating and lowers their PRCT price target from $56.00 to $51.00, on Dec 2, 2025.
Last year, PRCT revenue was $308.05M. In the past 5 year, PRCT's revenue has grown by 109.04% per year. This was faster than the Medical Devices industry average of 11.55%.
No, Procept Biorobotics doesn't provide an income stream by paying out dividends.
What others are saying about PRCT
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your PRCT trade
You have two main order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually fine.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at an exact price, place a limit order.
Click the Open button and your broker will place your order.
If you need more assistance investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Procept Biorobotics share?
As of Mar 18, 2026, it costs $26.17 to buy one share of Procept Biorobotics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.382 shares of PRCT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.